Publications
Recent Journal Articles
Are New Alzheimer Drugs Better than Older Drugs?
JAMA Internal Medicine
This article takes a critical look at the new monoclonal antibodies directed toward amyloid for Alzheimer’s Disease.
Challenging pharma: who cares?
Drug and Therapeutics Bulletin
This article examines pharma-critical organizations and how they fight against pharma’s attempts to mislead physicians and patients.
Making the Case for Accelerated Withdrawal of Aducanumab
Journal of Alzheimer's Disease
Pharmaceutical marketing: the example of drug samples
Journal of Pharmaceutical Policy and Practice
This article describes how drug samples are used as a promotional tool by the pharmaceutical industry.
Evergreened drugs or evergreened profits?
Journal of Evaluation in Clinical Practice
This article discusses patent extension tactics and their contribution to high drug costs.
Journal of American Dental Association
This survey outlines dentists' beliefs regarding opioids.
Pain Physician
A study that shows the industry-funded continuing education on opioids required by the FDA under a REMS misrepresents evidence and may increase, rather than decrease, opioid prescribing.
Industry-funded medical education is always promotion
British Medical Journal
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough
Journal of General Internal Medicine
The Physician Payments Sunshine Act has not changed physician, consumer, or patient behavior and more must be done to address industry relationships in medicine.
The Benefits and Risks of Adherence to Medical Therapy
Journal of Scientific Practice and Integrity
An exploration of the reasons for noncompliance to prescribed medication, its benefits and risks, and industry's stake in nonadherence.
Changing Pharmaceutical Industry Interaction in US Family Medicine Residencies: A CERA Study
Journal of the American Board of Family Medicine
Interactions between pharmaceutical companies and US family residency programs decreased between 2008 and 2019. The first 2008 study was conducted by PharmedOut interns.
Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective
Journal of Bioethical Inquiry
An examination of public health activism in the Progressive Era, the postwar era and the present day.
Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
Journal of the American Board of Family Medicine
Marketing messages in continuing medical education promote drugs used to treat binge-eating disorder and underplay their risks.
Response: Re: Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
PharmedOut's response to Medscape's critique of Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED) further exposed industry marketing messages in Medscape's CME.
World Medical & Health Policy
A study on marketing messages in continuing medical education on fentanyl products.